Cannabinoids are known to control the cell survival/death decision, leading to different
outcomes that depend on the nature of the target cell and its proliferative or differentiation …

Cannabinoids recently have been shown to control the cell survival/death decision. Thus,
cannabinoids induce growth arrest or apoptosis in a number of transformed neural and non …

Cannabinoids, the active components of Cannabis sativa (marijuana), and their derivatives
produce a wide spectrum of central and peripheral effects, some of which may have clinical …

Endocannabinoids are bioactive lipids that modulate various physiological processes
through G-protein-coupled receptors (CB1 and CB2) and other putative targets. By sharing …

Cannabinoids bind to two G‐protein‐coupled receptors, CB1 and CB2, expressed by
neurons and cells of the immune system, respectively. Glioma cells (astrocyte‐derived brain …

The endogenous canabinoid system (ECS) is involved in the regulation of an important
number of central and peripheral physiological effects. Among all these functions, the control …

According to the World Health Organization, the cases of death caused by cancer will have
been doubled until the year 2030. By 2010, cancer is expected to be the number one cause …

Cannabinoids are a group of structurally heterogeneous but pharmacologically related
compounds, including plant-derived cannabinoids, synthetic substances and endogenous …

Gliomas, in particular glioblastoma multiforme or grade IV astrocytoma, are the most
frequent class of malignant primary brain tumours and one of the most aggressive forms of …

Cannabis has been cultivated by man since Neolithic times. It was used, among others for
fiber and rope production, recreational purposes and as an excellent therapeutic agent. The …